SpaceX Is Down 30% Since Its Stellar Debut. Should You Buy It Now?

SpaceX has fallen 30% from its intraday high and is now trading below its first-day closing price, despite a strong three-day IPO debut. The article highlights multiple headwinds: xAI's strategic shift toward selling compute, a $25 billion bond offering, a valuation above 100x sales, and an upcoming lockup expiration that could add selling pressure. Management still expects Starship payload delivery in the second half of the year, but near-term upside appears limited versus downside risk.

Analysis

The post-IPO tape is likely being driven less by fundamental reassessment than by the classic mismatch between a tiny float and a story stock with enormous narrative optionality. Once the first wave of momentum buyers is exhausted, price discovery becomes dominated by supply overhang rather than buyers’ willingness to underwrite a multi-year vision, which is why these names often overshoot on the downside before fundamentals even matter.

The more important second-order issue is that the company is effectively asking public investors to finance two capital-intensive wars at once: launch-system maturation and AI infrastructure scaling. That creates a credibility problem — if the market starts to believe compute monetization depends on an immature rocket platform, then every incremental dollar of capex gets discounted more harshly, not less, because it raises execution risk without near-term proof points.

For the listed AI complex, the read-through is mixed but real. GOOGL and GS are cleaner beneficiaries of excess compute deals than the issuer itself because they gain exposure to AI capacity without funding binary launch risk; meanwhile NVDA benefits only indirectly if this ends up reinforcing demand for high-end accelerators, but any broad repricing of speculative AI infrastructure can compress multiples across the group. The bond raise is also a tell: near-term equity supply may be capped, but debt investors are effectively being asked to finance optionality, which can reset how the market prices future dilution risk.

The consensus may be underestimating how long lockup pressure and valuation compression can dominate even if launch milestones are met on schedule. If the next catalyst is only a technical launch update rather than a clear commercial payload cadence, the stock can keep drifting lower for months as early holders monetize and late buyers wait for a better entry. A real reversal likely requires either a visible Starship success sequence or a material de-risking of the AI monetization path; absent that, this remains a trader’s stock, not an investor’s stock.

Key Decisions for Investors

• Avoid initiating a new long in the IPO for the next 6-12 weeks; let float expansion and post-lockup supply clear before considering entry, because supply/demand pressure is more important than story momentum in the near term.
• If you want exposure to the AI infrastructure theme, express it via GOOGL or GS over the next 1-3 months rather than the issuer; both have more visible monetization and less binary execution risk.
• Trade the overhang with a short-dated bearish options structure on the stock if borrow is tight: buy 1-3 month put spreads to target continued drift lower while defining risk around a launch-related squeeze.
• For NVDA holders, do not add here on this headline; use the weakness to monitor whether AI capex enthusiasm is broadening or being questioned. If the market starts discounting AI infra spending more aggressively, trim cyclicality exposure into strength.
• Wait for a two-step confirmation before buying: a successful commercial payload milestone plus evidence of repeatable launch cadence. Without both, the risk/reward remains skewed to the downside despite the pullback.